Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
Intermittent preventive treatment (IPT) is used to reduce malaria morbidity and mortality, especially in vulnerable groups such as children and pregnant women. IPT with the fixed dose combination of piperaquine (PQ) and dihydroartemisinin (DHA) is being evaluated as a potential mass treatment to con...
Hoofdauteurs: | Permala, J, Tarning, J, Nosten, F, White, N, Karlsson, M, Bergstrand, M |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
American Society for Microbiology
2017
|
Gelijkaardige items
-
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
door: Chotsiri, P, et al.
Gepubliceerd in: (2019) -
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
door: Palang Chotsiri, et al.
Gepubliceerd in: (2019-01-01) -
Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
door: Bergstrand, M, et al.
Gepubliceerd in: (2014) -
Efficacy and safety of dihydroartemisinin-piperaquine.
door: Myint, H, et al.
Gepubliceerd in: (2007) -
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
door: Lwin, K, et al.
Gepubliceerd in: (2012)